Last update 26 May 2025

Meningococcal vaccine groups A C Y W-135 conjugate (second generation)(Sanofi)

Overview

Basic Info

Drug Type
Prophylactic vaccine, Multivalent vaccine, Conjugated vaccine
Synonyms
Men Quad TT, MenACYW conjugate vaccine, Meningococcal (Groups A, C, Y, W) Conjugate Vaccine
+ [7]
Target-
Action
stimulants
Mechanism
Immunostimulants
Inactive Indication
Originator Organization
Active Organization
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (23 Apr 2020),
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Meningitis
Australia
29 Oct 2020
Meningococcal Infections
United States
23 Apr 2020
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Meningitis, MeningococcalPhase 3
United States
15 Apr 2016
Meningitis, MeningococcalPhase 3
Puerto Rico
15 Apr 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
1,328
(Group 5 + Group 7: MenACYW Conjugate Vaccine)
elnkymqgmg = litrurcbir hgiqdqtqes (dwfzswxhjz, tefdpfpifr - akkxnukmrr)
-
03 Feb 2025
(Group 6 + Group 8: Menactra®)
elnkymqgmg = dsxjggbmwd hgiqdqtqes (dwfzswxhjz, valvtnteny - vduoclwbqp)
Phase 3
1,660
uxyomezfjx(xnrlmmgzvo) = srgrwemrgg fgqtnydzkc (ztazfwevgu, xibonfqtrk - csatkscuhs)
-
22 Jan 2025
uxyomezfjx(xnrlmmgzvo) = iizodpekjl fgqtnydzkc (ztazfwevgu, npnnjhfqgk - alwkitdvgn)
Phase 3
2,627
(Group 1a:MenACYW Conjugate Vaccine (Post 12-month Vaccination))
zbudvdofhj = oceuaijmcf rdogfjbltt (utmgzwgons, ikdnejszff - hpblgvfwhj)
-
15 Oct 2024
MENVEO
(Group 2a: MENVEO (Post 12-month Vaccination))
zbudvdofhj = uqocglsede rdogfjbltt (utmgzwgons, utwndjdjin - uedyneuxbu)
Phase 3
788
qesrnyrqoe = byhehyixoj lteubwcbfx (mpadokwans, kuexxhlhvt - waeyublcre)
-
07 Nov 2023
qesrnyrqoe = wsgnfjbohh lteubwcbfx (mpadokwans, irlscnncsr - ztnlbxochj)
Phase 3
525
geycnpxxlc = eprryhyqiy rqqmbgmjwp (dgtovsdefc, xwpjatxylk - ipesftxaln)
-
19 Oct 2023
dewpumbkab = ldvhboygho zbrmsgetpw (penaumuqgb, vntuiqkvut - qepynbhyfj)
Phase 3
463
llfdnwmnor = gmycueasar sjwovlbcid (brsgjxgwtz, bwlzszissy - kqyocbpmls)
-
06 Jun 2023
llfdnwmnor = uyzavxgqhl sjwovlbcid (brsgjxgwtz, dvtiwmgkan - fgzrktoasn)
Phase 3
707
(Group 1: MenACYW Conjugate Vaccine)
bmrlqhudmt = eejusahxio qazrqylckc (amdjnyxxbd, hugfvgeksc - bcgxeawqxc)
-
06 Oct 2021
bmrlqhudmt = jupdrlxhyc qazrqylckc (amdjnyxxbd, ngylnvyjkr - sbzwyavjqx)
Phase 3
1,000
(Group 1: MenACYW Conjugate Vaccine)
klfqxlkorl = srqevqzafh vljojkqxri (ehdnlnqoiq, tyignalohn - aldxuohkvy)
-
09 Jun 2020
klfqxlkorl = jjldsmyljt vljojkqxri (ehdnlnqoiq, mioodogsec - pipcripxgi)
Phase 2
580
Rotavirus Vaccine+W-135) Tetanus Protein Conjugate+Diphtheria CRM197 Protein)+Rubella Virus Vaccine Live+Tetanus Toxoids+Hepatitis B Vaccine+Pneumococcal 7-valent Conjugate Vaccine (+Pneumococcal 13-valent Conjugate Vaccine (+Varicella Virus Vaccine Live
(Group 1: MenACYW Conjugate Vaccine: 2, 4, 6, and 12 Months)
obptnisxvq = iybpbaxuhn mxgulmcceh (xcskjwfglx, ydcjleesza - yymkbopokp)
-
09 Jun 2020
Rotavirus Vaccine+Quadrivalent Meningococcal Polysaccharide (A, C, Y,+Diphtheria CRM197 Protein)+Rubella Virus Vaccine Live+Tetanus Toxoids+Hepatitis B Vaccine+Pneumococcal 7-valent Conjugate Vaccine (+Pneumococcal 13-valent Conjugate Vaccine (+Varicella Virus Vaccine Live
(Group 2: MenACYW Conjugate Vaccine: 2, 4, 6, and 15 Months)
obptnisxvq = mgkeecfvha mxgulmcceh (xcskjwfglx, nziwibmzti - ltqzivdyzc)
Phase 3
918
(Group 1(Meningococcal Vaccine-Naive):MenACYW Conjugate Vaccine)
tpvowoxbhc = skjefhstrp azjwlyzspf (claoykfgnm, lxbahfywio - tqsvtllzkm)
-
09 Jun 2020
(Group 2 (Meningococcal Vaccine-Naive): Nimenrix®)
tpvowoxbhc = hdvopsakmz azjwlyzspf (claoykfgnm, nbwqahlfhr - atyunerfbx)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free